# Moderna, Inc.: Form 8-K, filed Nov 24, 2025

- Company: [Moderna, Inc.](/companies/mrna.md) (CIK 1682852)
- Form: 8-K
- Filed: 2025-11-24
- Accepted by EDGAR: Nov 24, 2025, 21:29 ET
- Period: 2025-11-19
- Accession: 0001628280-25-053816
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1682852/000162828025053816/mrna-20251119.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1682852/000162828025053816/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1682852/000162828025053816/mrna-20251119.htm

Filed Nov 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-053816. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
